New research reveals UBX1325's potential to significantly improve vision in diabetic macular edema patients, offering hope ...

While many studies have focused on generating high-fidelity synthetic images for beneficial applications, very few have ...

Every year, millions of people around the world undergo detailed and time-consuming examinations to assess the health and ...

The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Private equity (PE) firms have increased their ownership stake across health care sectors in the US. PE’s focus on short-term profitability may decrease the provision of unprofitable services, ...

The following is a summary of “Recent advances and applications of optical coherence tomography angiography in diabetic ...

The following is a summary of “Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis,” published in the April 2025 issue of BMC Ophthalmology by Terheyden et al. Giant cell ...

The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.

Focus Point Vision Care Group Sdn Bhd proudly presents the Focus Point 360° APEC Roadshow in collaboration with Hoya Malaysia ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

EyePoint Pharmaceuticals, Inc.’s EYPT share price has surged by 6.87%, which has investors questioning if this is right time ...

Discover surprising truths about blindness, from the spectrum of visual impairment to revolutionary treatments and adaptive ...